November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
George Laliotis: Peri-operative FOLFIRINOX improved outcomes in patients with pancreatic cancer
Jun 26, 2024, 03:57

George Laliotis: Peri-operative FOLFIRINOX improved outcomes in patients with pancreatic cancer

George Laliotis, Translational Medicine Lead of GU Oncologist at shared a post by JAMA Oncology on X, adding:

Check our latest work.

Peri-operative FOLFIRINOX improved outcomes in patients with pancreatic cancer. ctDNA detection after surgery by Signatera was highly predictive of post-surgery outcomes. Promising data that support the integration of ctDNA in pancreatic cancer care management.”

Quoting the post by JAMA Oncology:

“Peri-operative modified FOLFIRINOX was safe and effective, with a clinically meaningful improvement in survival compared with historical controls.”

Visit the article website.
Source: George Laliotis/X and JAMA Oncology/X

.